We’re here to provide journalists with up-to-the-minute information, comments and statistics about pancreatic cancer, our work and activities – as quickly as possible.
As the biggest pancreatic cancer charity in the UK, and the only charity to provide support, fund research and campaign for change in pancreatic cancer, we can offer expert guidance and opinions on issues surrounding pancreatic cancer.
Our spokespeople
We can provide a range of spokespeople including people who have been affected by pancreatic cancer, and their families, and pancreatic cancer experts, including:
Latest news
-
4 June 2026
Just 12% of pancreatic cancer patients given the chance to join a clinical trial
Only 12% of people with pancreatic cancer are given the chance to take part in a clinical trial, emphasising the lack of progress in developing treatm...
Read more -
3 June 2026
We’re demanding treatment breakthroughs. We’re demanding survival.
Today marks the launch of our Demand Survival Now petition, calling on governments across the UK to fund more research for treatment breakthroughs
Read more -
31 May 2026
Our response to the daraxonrasib clinical study and KRAS inhibitors
Our comment on daraxonrasib results and the promising group of therapies known as KRAS inhibitors.
Read more
-
4 June 2026
Just 12% of pancreatic cancer patients given the chance to join a clinical trial
Only 12% of people with pancreatic cancer are given the chance to take part in a clinical trial, emphasising the lack of progress in developing treatm...
Read more -
3 June 2026
We’re demanding treatment breakthroughs. We’re demanding survival.
Today marks the launch of our Demand Survival Now petition, calling on governments across the UK to fund more research for treatment breakthroughs
Read more -
31 May 2026
Our response to the daraxonrasib clinical study and KRAS inhibitors
Our comment on daraxonrasib results and the promising group of therapies known as KRAS inhibitors.
Read more